Divalproex Sodium
Product Images NDC 21695-819
Product Visual Gallery
This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Divalproex Sodium (NDC 21695-819). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Rebel Distributors Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Figure 1 Percentage Of Patients Achieving ≥ 30% Reduction In Symptom Score From Baseline (9b3db659 F64c 4c48 946a 6b4f1d800eba 02)
Figure 2 Mean 4-week Migraine Rates (9b3db659 F64c 4c48 946a 6b4f1d800eba 03)
Figure 3 Presents Proportion Of Patients In The Adjunctive Therapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 04)
Figure 4 Presents Proportion Of Patients In The Monotherapy Study (9b3db659 F64c 4c48 946a 6b4f1d800eba 05)
Divalproex Sodium 125mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 06)
Divalproex Sodium 250mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 07)
Divalproex Sodium 500mg (9b3db659 F64c 4c48 946a 6b4f1d800eba 08)
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.